Bengt Westermark

Bengt Westermark

Direktor/Vorstandsmitglied bei MEDIVIR AB
81 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Bengt Westermark is the founder of Mesenkia Therapeutics AB, serving as Chairman since 2023.
Current jobs include Independent Director at Medivir AB since 2017, Member of the Royal Swedish Academy of Sciences, Professor at the University of Uppsala since 2002, Member of the European Molecular Biology Organization, Member of the Royal Society of Sciences, and Member of The European Academy of Cancer Sciences.
Former jobs include Chairman-Research Board at The Swedish Cancer Society from 2003 to 2013, Independent Director at Medivir AB from 2017 to 2021, and Director at Hamlet BioPharma AB.

Aktive Positionen von Bengt Westermark

UnternehmenPositionBeginn
MEDIVIR AB Direktor/Vorstandsmitglied 01.01.2017
Corporate Officer/Principal 01.01.1986
Corporate Officer/Principal -
European Molecular Biology Organization
Corporate Officer/Principal -
Royal Society of Sciences
Corporate Officer/Principal -
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Bengt Westermark

UnternehmenPositionEnde
MEDIVIR AB Direktor/Vorstandsmitglied 05.05.2021
The Swedish Cancer Society
Corporate Officer/Principal 01.01.2013
HAMLET PHARMA AB (PUBL) Direktor/Vorstandsmitglied -
Sehen Sie sich die Erfahrung von Bengt Westermark im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

81

Beziehungen ersten Grades

8

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen8

Health Technology

Commercial Services

Consumer Services

The Swedish Cancer Society

European Molecular Biology Organization

Health Technology

Royal Society of Sciences

Commercial Services

  1. Börse
  2. Insiders
  3. Bengt Westermark